Preconception Bloodwork After 35: Tests to Ask Your Doctor About

Before trying to conceive after 35, many women and their healthcare providers consider a preconception evaluation — a review of health history, lifestyle factors, and a targeted set of lab tests designed to identify conditions that could affect fertility, pregnancy, or the health of a future pregnancy. The specific tests that are recommended vary based on individual medical history, but understanding the categories of testing that are commonly discussed can help make a preconception appointment more productive.

Ads

This overview covers the main categories of preconception bloodwork that may be relevant for women over 35, why each is typically ordered, and what the results may prompt in terms of follow-up. Whether specific tests are appropriate for any individual is a conversation for a healthcare provider familiar with their history.

What Research Shows About Preconception Care

According to the American College of Obstetricians and Gynecologists (ACOG), preconception care — including relevant testing — is recommended for all women planning pregnancy, with particular attention to factors that become more common or more clinically significant with age. Identifying and addressing modifiable risk factors before conception is generally considered more effective than managing them after a pregnancy is established. For women over 35, a few categories of testing tend to be discussed more consistently than at younger ages.

Ovarian Reserve and Hormone Panel

For women over 35 who are planning to conceive — especially those who have been trying without success — ovarian reserve testing is one of the most commonly discussed components of a preconception or fertility evaluation.

AMH (Anti-Müllerian Hormone)

Ads

AMH is produced by small follicles in the ovaries and is currently the most widely used marker of ovarian reserve. Lower AMH levels are associated with a smaller remaining pool of eggs, though AMH alone doesn’t predict whether conception will occur. It’s useful primarily for informing decisions about timing, treatment approach, and the likely response to ovarian stimulation if IVF is being considered. AMH can be drawn on any day of the cycle.

FSH and Estradiol (Day 3)

Follicle-stimulating hormone (FSH) and estradiol are typically measured on day 2 or 3 of the menstrual cycle. Elevated FSH can reflect declining ovarian reserve; estradiol is measured alongside it because a high estradiol level can suppress FSH and produce a falsely normal result. Together, these provide information complementary to AMH.

Antral Follicle Count (AFC)

An antral follicle count is performed via transvaginal ultrasound rather than blood test, but it’s frequently part of the same ovarian reserve evaluation. It counts the small resting follicles visible in each ovary, providing another indicator of the egg pool. AFC is typically ordered by a reproductive endocrinologist as part of a full fertility workup rather than at a primary care visit.

For context on how ovarian reserve testing fits into a broader treatment planning process, the range of IVF-related costs after 35 is often discussed alongside reserve results when treatment options are being evaluated.

Thyroid Function

Thyroid disorders — particularly hypothyroidism — are more prevalent in women than men and become more common with age. Both overt and subclinical hypothyroidism have been associated with fertility challenges and pregnancy complications in research literature, making thyroid screening a standard component of many preconception evaluations.

TSH (Thyroid-Stimulating Hormone)

TSH is the primary screening test for thyroid function. Many reproductive endocrinologists and obstetricians apply a stricter TSH target for women who are pregnant or trying to conceive (often below 2.5 mIU/L) than the standard laboratory reference range, which may be up to 4.5 or 5.0 mIU/L. A TSH result in the “normal” range from a general lab panel may prompt further discussion with an OB/GYN or RE who is familiar with preconception targets.

Thyroid Antibodies (TPO and Anti-Tg)

In some cases, providers order thyroid peroxidase (TPO) antibodies or anti-thyroglobulin antibodies to check for autoimmune thyroid disease (Hashimoto’s thyroiditis), which can affect thyroid function over time and has been associated with early pregnancy loss in some research. Whether antibody testing is recommended depends on individual history and TSH results.

Immunity and Infectious Disease Screening

Several immunity and infectious disease tests are standard components of preconception or early prenatal care, particularly for women over 35 who may not have had recent screening:

Rubella immunity — Rubella (German measles) infection during pregnancy can cause serious fetal complications. Checking immunity via antibody titer before pregnancy allows for vaccination if needed (vaccination is not given during pregnancy).
Varicella immunity — Similarly, varicella (chickenpox) immunity is checked; non-immune women may be vaccinated before attempting conception.
Hepatitis B and C — Screening for hepatitis B surface antigen and hepatitis C antibody is standard, as both can be transmitted to a fetus and affect pregnancy management.
HIV — HIV testing is recommended as part of routine preconception care.
STI screening (chlamydia, gonorrhea) — Untreated chlamydia or gonorrhea can affect fertility and pregnancy; screening at a preconception visit is standard in many guidelines.

General Health Panel

Beyond fertility-specific and immunity testing, a preconception visit often includes a general health assessment that may involve:

Complete blood count (CBC) — Screens for anemia, which is common in reproductive-age women and can affect both fertility and pregnancy outcomes if unaddressed.
Blood type and Rh factor — Rh-negative blood type requires specific management during pregnancy (Rh immunoglobulin administration) to prevent complications in subsequent pregnancies.
Blood glucose/HbA1c — Uncontrolled diabetes increases risks during early pregnancy, including neural tube defects. Identifying and managing diabetes or prediabetes before conception is considered an important preconception goal.
Blood pressure — Chronic hypertension is a risk factor for pregnancy complications including preeclampsia and is more prevalent with age.
Vitamin D — Low vitamin D is common and has been studied in relation to fertility and pregnancy; testing allows for supplementation if levels are below optimal range.

Genetic Carrier Screening

Expanded carrier screening — testing for conditions like cystic fibrosis, spinal muscular atrophy, fragile X syndrome, and hundreds of other genetic conditions — is increasingly offered before or during pregnancy. ACOG recommends offering carrier screening to all women who are pregnant or considering pregnancy.

For women over 35, carrier screening is typically discussed alongside prenatal genetic testing options (such as cell-free DNA screening and amniocentesis) as separate but complementary parts of genetic risk assessment. Understanding what pregnancy after 35 involves overall can provide useful context for these conversations.

Carrier screening identifies whether a person carries one copy of a gene mutation associated with a recessive condition — meaning they are carriers but don’t have the condition themselves. If both partners carry a mutation for the same recessive condition, there is a risk of having an affected child. This is why partner testing often follows a positive carrier screening result.

Frequently Asked Questions

When should I schedule a preconception appointment?

Most guidelines suggest scheduling a preconception visit approximately three to six months before actively trying to conceive. This allows time for any identified conditions to be addressed — such as adjusting thyroid medication, completing vaccinations, or optimizing blood glucose control — before a pregnancy begins. For women over 35 who have already been trying to conceive for six months or more without success, a referral to a reproductive endocrinologist may be appropriate alongside or instead of a standard preconception visit with a primary care provider.

Does insurance typically cover preconception bloodwork?

Coverage varies considerably by plan. Routine preventive screening (such as thyroid testing, CBC, and immunity checks) is often covered under preventive care benefits. Fertility-specific testing — including AMH and ovarian reserve panels — may or may not be covered depending on the plan, the diagnosis code used, and the state. Confirming with your insurance before ordering tests, and understanding how coverage for fertility-related care works under your plan, can prevent unexpected costs.

Is preconception bloodwork the same as early pregnancy bloodwork?

There is overlap, but they’re not identical. Preconception bloodwork is done before conception to identify and address modifiable risk factors. Early prenatal bloodwork (typically drawn at the first prenatal appointment around 8–10 weeks) includes many of the same tests — blood type, CBC, immunity screening, STI testing — but is focused on establishing a baseline for the current pregnancy and identifying conditions that need management during it. Some testing, like rubella and varicella vaccination if needed, must happen before conception rather than during pregnancy.

Should my partner also have preconception testing?

Male factor infertility accounts for a meaningful proportion of couples experiencing difficulty conceiving, and a semen analysis is a relatively low-cost, non-invasive starting point for evaluating the male partner’s contribution to fertility. Genetic carrier screening can also be done by partners to assess combined risk for recessive conditions. Most reproductive endocrinologists recommend evaluating both partners early in a fertility workup rather than focusing exclusively on female-side testing.

Key Takeaways

Preconception bloodwork after 35 commonly includes ovarian reserve markers (AMH, FSH/estradiol), thyroid function, immunity screening, and general health panels.
Thyroid TSH targets for women trying to conceive are often stricter than standard lab reference ranges — a finding worth discussing specifically with an OB/GYN or RE.
Genetic carrier screening is recommended for all women planning pregnancy and is separate from age-related prenatal testing like NIPT or amniocentesis.
Coverage for fertility-specific tests (AMH, ovarian reserve panels) varies by insurance plan; confirming coverage before ordering tests can help with planning.
Evaluating both partners early in a fertility workup — rather than focusing only on female-side testing — is standard practice in reproductive medicine.

Preconception Bloodwork After 35: Which Tests to Ask Your Doctor About